<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
 <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
 <link rel="stylesheet" type="text/css" href="savehtml.css"/>
 <title>Avpr1a --+&gt; vasoconstriction
 </title>
</head>
<body>
 <div class="props">
  <h1>Regulation Avpr1a --+&gt; vasoconstriction</h1>
  <table>
   <tbody>
    <tr>
     <th align="left">Owner
     </th>
     <td>Public
     </td>
    </tr>
    <tr>
     <th align="left">URN
     </th>
     <td>urn:agi-Regulation:inout-urn:agi-llid:552:out-urn:agi-gocellproc:0042310::unknown
     </td>
    </tr>
    <tr>
     <th align="left">References
     </th>
     <td>12
     </td>
    </tr>
    <tr>
     <th align="left">Connectivity
     </th>
     <td>2
     </td>
    </tr>
    <tr>
     <th align="left">Effect
     </th>
     <td>unknown
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10564825&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10564825:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Arginine vasopressin interacts with the vasopressin type 1a receptor (V1aR) to initiate physiological effects such as vasoconstriction of blood vessels and glycogenolysis.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12724283&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12724283:0
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>The arginine vasopressin (AVP) type 1a receptor (V1a) is well known to mediate vasoconstriction.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpregu.physiology.org/cgi/content/full/282/4/R979" target="AGI_EXT_REF">http://ajpregu.physiology.org/cgi/content/full/282/4/R979
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">CellLineName
     </th>
     <td>VSMCs
     </td>
    </tr>
    <tr>
     <th align="left">CellType
     </th>
     <td>hepatocyte
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11893600&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11893600:10154
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Together, our data suggest that proinflammatory cytokines downregulate V1A receptor expression during sepsis, causing an attenuation of the V1A receptor-mediated vasoconstriction.
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Reg.Int.Comp.Phys
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v282 i4 pR979
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.ebmonline.org/cgi/content/full/229/10/1061" target="AGI_EXT_REF">http://www.ebmonline.org/cgi/content/full/229/10/1061
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>brain
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15522843&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15522843:10230
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>V1a, unlike V2a, is recognized to initiate vasoconstriction upon binding of its ligand vasopressin (anti-diuretic hormone, ADH).
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>EBM
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v229 i10 p1061
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Organ
     </th>
     <td>kidney
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11330329&amp;dopt=AbstractPlus" target="AGI_EXT_REF">11330329:3
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Oxytocin-evoked renal vasoconstriction was abolished by SR 49059, a selective vasopressin V1A receptor antagonist (10 nM), but not by d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-(NH2)9] vasotocin, an oxytocin receptor antagonist (10 nM).
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajprenal.physiology.org/cgi/content/full/290/2/F273" target="AGI_EXT_REF">http://ajprenal.physiology.org/cgi/content/full/290/2/F273
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>kidney
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16189291&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16189291:10182
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>A theoretical problem could arise because the circulating AVP, which can no longer bind to the V 2 receptor, is available to bind to the V 1A receptor, which mediates vasoconstriction.
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Renal Phys
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v290 i2 p273
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajpendo.physiology.org/cgi/content/full/285/6/E1161" target="AGI_EXT_REF">http://ajpendo.physiology.org/cgi/content/full/285/6/E1161
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>smooth muscle
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12915399&amp;dopt=AbstractPlus" target="AGI_EXT_REF">12915399:10122
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Another major action of AVP is vasoconstriction, which is mediated by V1aR in vascular smooth muscle cells.
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Endocrin. Metabol
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v285 i6 pE1161
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://jpet.aspetjournals.org/cgi/content/full/293/3/852" target="AGI_EXT_REF">http://jpet.aspetjournals.org/cgi/content/full/293/3/852
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>smooth muscle
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10869385&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10869385:10029
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Activation of the V 1a receptor has been shown to cause peripheral vasoconstriction (Riegger and Leibau, 1982 ; Manning et al., 1993 ; Bichet, 1994 , Burrell et al., 1994 ).
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>JPET
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v293 i3 p852
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Tissue
     </th>
     <td>vascular
     </td>
    </tr>
    <tr>
     <th align="left">Organ
     </th>
     <td>renal
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10731046&amp;dopt=AbstractPlus" target="AGI_EXT_REF">10731046:8
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>In the presence of SR 49059 (1 mg/kg i.v.), a vasopressin V1A receptor antagonist that completely abolished the vasopressin-induced renal vasoconstriction, desmopressin again failed to induce vasodilation.
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://www.pnas.org/cgi/content/full/103/20/7807" target="AGI_EXT_REF">http://www.pnas.org/cgi/content/full/103/20/7807
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>endothelial
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16682631&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16682631:10137
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Sentence
     </th>
     <td>Therefore, the magnitude of the BP increase seen after in vivo administration of AVP actually represents a summation of V1a receptor-mediated vasoconstriction and V2 receptor/NO-mediated vasodilatation.
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>PNAS
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v103 i20 p7807
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajprenal.physiology.org/cgi/content/full/291/1/F218" target="AGI_EXT_REF">http://ajprenal.physiology.org/cgi/content/full/291/1/F218
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>medulla
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16478974&amp;dopt=AbstractPlus" target="AGI_EXT_REF">16478974:10025
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Renal Phys
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v291 i1 p218
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
  <table>
   <tbody>
    <tr>
     <th align="left">Journal Link
     </th>
     <td>
      <a href="http://ajprenal.physiology.org/cgi/content/full/288/6/F1249" target="AGI_EXT_REF">http://ajprenal.physiology.org/cgi/content/full/288/6/F1249
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Tissue
     </th>
     <td>vascular
     </td>
    </tr>
    <tr>
     <th align="left">MedLine Reference
     </th>
     <td>
      <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15657301&amp;dopt=AbstractPlus" target="AGI_EXT_REF">15657301:10028
      </a>
     </td>
    </tr>
    <tr>
     <th align="left">Journal
     </th>
     <td>Renal Phys
     </td>
    </tr>
    <tr>
     <th align="left">Journal Reference
     </th>
     <td>v288 i6 p1249
     </td>
    </tr>
   </tbody>
  </table>
  <hr/>
 </div>
</body>
</html>